Navigation Links
Zactima Receives Fast Track Designation By The FDA

ZACTIMA a product of AstraZeneca has been granted fast track designation by the US Food and Drug Administration (FDA). The drug also received the orphan drug designation // recently for treatment of anaplastic, medullary, follicular, locally advanced and metastatic medullary thyroid cancer. Following the approval, investigation of the drug in the treatment of medullary thyroid carcinoma is expected to accelerate further.

Medullary thyroid cancer accounts for 5 to 10% of all thyroid cancers. Surgery, nuclear medicine (treatment with radioactive iodine), hormonal manipulation, external beam radiotherapy (direction of radiation to kill cancer cells from outside the body) and chemotherapy represent some of the available treatment options.

Presently, there is no satisfactory chemotherapy regimen or other treatment modality for the cure of advanced thyroid cancer. Only those drugs, used for the treatment of severe diseases for which there is an unfulfilled medical need would be granted fast-track status by the FDA.

The fast track review by the FDA would be of immense help in the development of the drug and regulation of the submission process. The pharmaceutical company is currently involved in Phase II clinical trials of the drug, directed against metastatic or locally advanced medullary thyroid cancer.

The compound is believed to play a major role in the inhibition of the growth and spread of the thyroid cancer by participating in vital cell signalling pathways. Vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EFGR) participate in the inhibition pathway while REarranged during Transfection (RET) tyrosine kinases can accelerate the growth of the same.

If the treatment is found to be successful, then we might soon have a new treatment modality for the treatment of medullary thyroid cancer.


'"/>




Page: 1

Related medicine news :

1. Fifth US Patient Receives Artificial Heart
2. Northfield Labs Receives FDA Comments
3. British MPs Say Prostate Cancer Receives Low Priority in the NHS
4. Abbott Receives CE Mark Certification
5. East London Receives World Class New Private Hospital Facility
6. Brinda Karat Receives Legal Notice over Ramdev Issue
7. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
8. Medtronic’s Insulin Pump Receives Regulatory Approva
9. Aurobindo Receives Approval from USFDA for anti-AIDS drug
10. Sunscreen Blocking UVA Radiation Receives Federal Approval
11. Eddie Thompson Receives Advanced Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... 2020 , ... Devcool Inc ( http://www.devcool.com ), a ... its spin-off of HiPaaS, Inc ( http://www.hipaas.com ). HiPaaS Inc will focus ... growth and focuses on Healthcare consulting services. , With HiPaaS, companies can ...
(Date:1/24/2020)... ... January 24, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Dr. Homa Assadi ... and research site in Toronto, Canada. , Dr. Assadi’s extensive experience pertains to ...
(Date:1/23/2020)... YORK (PRWEB) , ... January 23, 2020 , ... The ... Diversity” by Forbes and research firm Statista. , Mount Sinai was ranked No. 3 ... more than 20 industries. The Health System is New York City’s largest academic medical ...
(Date:1/23/2020)... ... January 23, 2020 , ... The American Heart Association ... announced that their Annual Ventura County Go Red for Women Luncheon will ... Four Seasons Westlake Village. Approximately 500 residents are anticipated to attend the premier event ...
(Date:1/23/2020)... ... ... SignatureCare Emergency Center is set to expand to North Dallas with the opening of ... of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, the new location will ... It will serve residents and businesses around Lewisville, TX, including Double Oak, Copper Canyon, ...
Breaking Medicine News(10 mins):
(Date:1/25/2020)... ... January 25, 2020 , ... ... Vanessa Belozeroff, Executive Director, Global Program Management, Biosimilars Division of Amgen, has been ... , "Vanessa has over twenty five years of strategic global drug development and ...
(Date:1/24/2020)... GAITHERSBURG, Md. (PRWEB) , ... January 24, 2020 ... ... cloud-based business resilience solutions, announces z/Archive, a new low-cost object storage solution using ... with a simple and inexpensive way to move older data to cloud storage, ...
(Date:1/24/2020)... ... January 24, 2020 , ... Each year Therapy and Beyond, ... organizations to host Mom’s Mingles that are designed for 100+ moms of children with ... same journey, and ultimately, enjoy a night of carefree fun. The highly anticipated 3rd ...
Breaking Medicine Technology: